skip to primary navigationskip to content
 

Marginal zone B cell role in immune homeostasis in response to high cholesterol diet

last modified May 19, 2017 10:53 AM

Prof Ziad Mallat, Dr Meritxell Nus, Dr Andrew Sage, and others have discovered a new role for margical zone B cells in immune homeostasis in response to high cholesterol diet.

Marginal zone B cells belong to the B2 subset of B cells that have previously been thought to be atherogenic. However, the specific role of marginal zone B cells in atherosclerosis has not been studied until now.

In a study published in Nature Medicine, Prof Mallat's team has developed a mouse model that lacks marginal zone B cells. Surprisingly, the animals developed atherosclerotic lesions faster than expected.

In control mice, marginal zone B cells were found to express a protein called Pdl1 at a high level, and this expression increased further after mice were fed a high cholesterol diet. Pdl1 binds to a protein called PD1 on the surface of a T follicular helper cells and transmits an inhibitory signal. These T follicular helper cells were demonstrated to be atherogenic in previous experiments.

Thus when marginal zone B cells binds through Pdl1 to Pd1 on T follicular helper cells they inhibit their motility and activation thus protecting the individual from atherosclerosis.

This interaction between marginal zone B cells and T follicular helper cells was unexpected, as they were believed not to be physically in contact. The team has shown that in response to a high cholesterol diet, marginal zone B cells migrate to the T cell zone where they bind to precursors of T follicular helper cells inhibiting their motility.

This discovery has translational implications because blood marginal zone-like B cells also express very high levels of Pdl1 in humans. Furthermore, the applicability of this discovery is not only limited to atherosclerosis but has a broad range of applications in cancer and other conditions.

Cambridge Cardiovascular logo - transparent

Logo design by Dr Ana-Mishel Spiroski and Dr Sarah Morgan.

 

We connect cardiovascular researchers in Cambridge.

Please follow us on Twitter for local news about research, events, funding calls, and open positions.

For inquiries about our research or the website, please contact Dr Katja Kivinen.